PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ravuconazole. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

27 hits

Bibliografisk träff 2022-05-06

Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.

Nyuykonge B, Lim W, van Amelsvoort L, Bonifaz A, Fahal A, Badali H, Abastabar M, Verbon A, van de Sande W.

Mycoses · research-article; journal article · DOI 10.1111/myc.13442

Bibliografisk träff 2022-02-04

Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma.

Lim W, Nyuykonge B, Eadie K, Konings M, Smeets J, Fahal A, Bonifaz A, Todd M, Perry B, Samby K, Burrows J, Verbon A, van de Sande W.

PLoS Negl Trop Dis · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pntd.0010159

Bibliografisk träff 2022-02-01

Development of a stability-indicating assay method by HPLC-DAD and MS characterization of forced degradation products of ravuconazole.

Gazzinelli BP, Brêtas CM, César IC.

J Chromatogr Sci · journal article · DOI 10.1093/chromsci/bmab064

Bibliografisk träff 2021-08-08

Higher oral efficacy of ravuconazole in self-nanoemulsifying systems in shorter treatment in experimental chagas disease.

Spósito PÁ, Mazzeti AL, de Castro KCMP, Mendes PF, Urbina JA, Bahia MT, Mosqueira VCF.

Exp Parasitol · journal article · DOI 10.1016/j.exppara.2021.108142

Bibliografisk träff 2021-03-05

In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates.

Dong J, Liang G, Zheng H, Kan S, Song N, Zhang M, Liu W.

Mycoses · journal article · DOI 10.1111/myc.13260

Bibliografisk träff 2020-08-20

<i>In Vitro</i> Activities of Ravuconazole and Isavuconazole against Dematiaceous Fungi.

Zheng H, Song N, Mei H, Dong J, Li D, Li X, Liu W.

Antimicrob Agents Chemother · brief-report; research support, non-u.s. gov't; journal article · DOI 10.1128/aac.00643-20

Bibliografisk träff 2020-08-01

In vitro algaecid effect of itraconazole and ravuconazole on Prototheca species.

Miura A, Kano R, Ito T, Suzuki K, Kamata H.

Med Mycol · journal article · DOI 10.1093/mmy/myz119

Bibliografisk träff 2020-07-22

Amlodipine Increases the Therapeutic Potential of Ravuconazole upon Trypanosoma cruzi Infection.

Machado YA, Bahia MT, Caldas IS, Mazzeti AL, Novaes RD, Vilas Boas BR, Santos LJS, Martins-Filho OA, Marques MJ, Diniz LF.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.02497-19

Bibliografisk träff 2020-01-01

Antifungal Susceptibility of Clinical Isolates and Artificially Produced Multi-azole-resistant Strains of Cryptococcus neoformans (formerly: Cryptococcus grubii) to Ravuconazole.

Kano R, Sugita T, Kamata H.

Med Mycol J · journal article · DOI 10.3314/mmj.19-00016

Bibliografisk träff 2019-12-25

In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients.

Kano R, Hiruma J, Yokota M, Noguchi H, Hase M, Kamata H, Harada K, Hiruma M.

Jpn J Infect Dis · journal article · DOI 10.7883/yoken.jjid.2019.265

Bibliografisk träff 2019-11-25

Antifungal susceptibility of dermatophyte isolates from companion animals to ravuconazole.

Kano R, Huruta H, Kamata H.

Vet Dermatol · letter · DOI 10.1111/vde.12815

Bibliografisk träff 2018-09-01

In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis.

Teixeira de Macedo Silva S, Visbal G, Lima Prado Godinho J, Urbina JA, de Souza W, Cola Fernandes Rodrigues J.

J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dky229

Bibliografisk träff 2018-05-16

Clinical Drug-Drug Interaction Potential of BFE1224, Prodrug of Antifungal Ravuconazole, Using Two Types of Cocktails in Healthy Subjects.

Ishii Y, Ito Y, Matsuki S, Sanpei K, Ogawa O, Takeda K, Schuck EL, Uemura N.

Clin Transl Sci · clinical trial; research-article; journal article · DOI 10.1111/cts.12557

Bibliografisk träff 2017-05-17

Ravuconazole self-emulsifying delivery system: in vitro activity against <i>Trypanosoma cruzi</i> amastigotes and in vivo toxicity.

Spósito PÁ, Mazzeti AL, de Oliveira Faria C, Urbina JA, Pound-Lana G, Bahia MT, Mosqueira VF.

Int J Nanomedicine · research-article; journal article · DOI 10.2147/ijn.s133708

Bibliografisk träff 2016-01-01

Potential of Ravuconazole and its Prodrugs as the New OralTherapeutics for Onychomycosis.

Yamaguchi H.

Med Mycol J · review; journal article · DOI 10.3314/mmj.16-00006

Bibliografisk träff 2014-06-19

Madurella mycetomatis is highly susceptible to ravuconazole.

Ahmed SA, Kloezen W, Duncanson F, Zijlstra EE, de Hoog GS, Fahal AH, van de Sande WW.

PLoS Negl Trop Dis · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pntd.0002942

Bibliografisk träff 2014-01-01

[In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].

Yamaguchi H, Ikeda F, Iyoda T, Suzuki M, Mikawa T.

Med Mycol J · comparative study; journal article · DOI 10.3314/mmj.55.j157

Bibliografisk träff 2013-09-23

Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans.

Elizondo-Zertuche M, Robledo-Leal E, González JG, Ceceñas LA, González GM.

Rev Iberoam Micol · comparative study; journal article · DOI 10.1016/j.riam.2013.09.006

Bibliografisk träff 2013-02-01

Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.

Watt K, Manzoni P, Cohen-Wolkowiez M, Rizzollo S, Boano E, Jacqz-Aigrain E, Benjamin DK.

Curr Drug Metab · research support, non-u.s. gov't; research-article; review; journal article; research support, n.i.h., extramural · DOI 10.2174/1389200211314020007

Bibliografisk träff 2012-05-15

Hybrids of ravuconazole: synthesis and biological evaluation.

Gaikwad ND, Patil SV, Bobade VD.

Eur J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejmech.2012.05.010

Bibliografisk träff 2010-04-19

Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.

Diniz Lde F, Caldas IS, Guedes PM, Crepalde G, de Lana M, Carneiro CM, Talvani A, Urbina JA, Bahia MT.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.01742-09

Bibliografisk träff 2010-02-01

Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.

Pasqualotto AC, Thiele KO, Goldani LZ.

Curr Opin Investig Drugs · review; journal article

Bibliografisk träff 2008-07-01

Nonclinical pharmacokinetics of BMS-292655, a water-soluble prodrug of the antifungal ravuconazole.

Knipe JO, Mosure KW.

Biopharm Drug Dispos · journal article · DOI 10.1002/bdd.612

Bibliografisk träff 2001-12-01

Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice.

Clemons KV, Stevens DA.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.45.12.3433-3436.2001

Bibliografisk träff 1999-02-01

ER 30346. BMS 207147.

Författaruppgift saknas

Drugs R D · journal article · DOI 10.2165/00126839-199901020-00013

Bibliografisk träff 1998-02-01

In vitro activity of a new oral triazole, BMS-207147 (ER-30346)

Fung-Tomc JC, Huczko E, Minassian B, Bonner DP.

Antimicrob Agents Chemother · comparative study; research-article; journal article · DOI 10.1128/aac.42.2.313

Bibliografisk träff 1996-10-01

In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.

Hata K, Kimura J, Miki H, Toyosawa T, Nakamura T, Katsu K.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.40.10.2237